Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Diabetes Prevention Through Genetics, Familial History and Behavior Change

6 september 2026 uppdaterad av: Candice Alick, PhD, Morehouse School of Medicine

Legacy-DPP: Diabetes Prevention Through Genetics, Familial History and Behavior Change A Family-Enhanced, Genetically-Informed Diabetes Prevention Program

The goal of this clinical trial is to learn if adding a family engagement component to the standard Diabetes Prevention Program (DPP) improves outcomes for adults with prediabetes. It will also learn about the effects of this approach on family members' health.

The main questions it aims to answer are:

  • Does adding family health history collection and family participation to the DPP improve session attendance compared to standard DPP?
  • Does this family-centered approach lead to greater weight loss and HbA1c (blood sugar) reduction compared to standard DPP?
  • Do health improvements extend to participants' family members, and what factors explain differences in family-level outcomes?

Researchers will compare an adapted DPP with a family component to the standard DPP (individual-focused) to see if involving family members improves diabetes prevention outcomes.

Participants will:

  • Be assigned to one of two groups: adapted DPP with family sessions, or standard DPP
  • If assigned to the adapted DPP, complete a family health history using the CDC's My Family Health Portrait tool and attend 6 additional sessions with family members focused on personalized risk communication
  • Attend regular checkups to measure weight and HbA1c at 6 and 12 months
  • Have session attendance tracked throughout the program
  • Family members of participants may also be asked to complete health assessments to measure any changes in their own health behaviors

Studieöversikt

Status

Har inte rekryterat ännu

Intervention / Behandling

Detaljerad beskrivning

Type 2 diabetes affects 38.4 million U.S. adults, and an additional 97.6 million adults have prediabetes and are at risk of developing the disease. This burden falls disproportionately on racial and ethnic minority families and rural communities.

This clinical trial aims to determine whether embedding family engagement and family health history into the Diabetes Prevention Program (DPP) improves adherence, weight loss, and glycemic outcomes among adults with prediabetes, compared to the standard individual-focused DPP.

Participants will be 200 index participants with prediabetes, along with their family members, recruited from rural and urban sites and stratified by geographic location. Index participants will be block randomized to receive either standard DPP or an adapted version that adds 6 weeks of family health history and genetics education-using the CDC's My Family Health Portrait tool-paired with family participation and skill-building sessions.

All participants will attend regular clinic visits to monitor weight and HbA1c at 6 and 12 months and will have session attendance tracked throughout. Family members will also complete health assessments to measure whether health improvements extend beyond the index participant, and researchers will use the Actor-Partner Interdependence Model to identify factors explaining variation in family-level outcomes.

This is a 2-arm randomized controlled trial comparing standard DPP to a family-adapted DPP incorporating family health history, genetics education, and family skill-building.

Studietyp

Interventionell

Inskrivning (Beräknad)

400

Fas

  • Fas 2
  • Fas 3

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

Studera Kontakt Backup

  • Namn: Candice L Alick, PhD
  • Telefonnummer: 404-752-1009
  • E-post: calick@msm.edu

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen
  • Äldre vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • Age ≥18 years.
  • Fasting HbA1c 5.7-6.4% confirmed by CLIA-waived point-of-care testing.
  • BMI ≥25 kg/m².
  • Able to provide informed consent.
  • Has an adult household/family or framily (fictive kin) member willing to enroll as a paired participant.
  • Willing to attend in-person sessions

Exclusion Criteria:

  • Minors <18 years
  • Prior diagnosis of T1 or T2D.
  • HbA1c ≥6.5% at screening (Aim 1/2 curriculum eligibility)
  • Current glucose-lowering medication use
  • Pregnancy
  • Physical-activity contraindications
  • Individuals unable to speak or understand English

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Förebyggande
  • Tilldelning: Randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Lifestyle Engagement through Genetics and Collaborative familY DPP (LEGACY DPP)
Participants will receive the LEGACY DPP intervention

The index partner will participate in an adapted DPP as a dyad with a family member with family health history and family participation and skill building

Participants will receive

  • family health history sessions
  • core behavioral weight loss group sessions
  • a family skill building segment covering cohesion and communication during core sessions
Aktiv komparator: Diabetes Prevention Program (DPP)
Participants will receive the DPP intervention

The index partner will participate in standard DPP

Participants will receive

- core behavioral weight loss group sessions

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Percent change in body weight
Tidsram: Baseline, 6 months, 12 months
Body weight (kg) expressed as a continuous variable will be collected on a digital scale.
Baseline, 6 months, 12 months

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Mean Change in Blood Pressure
Tidsram: Baseline, 6 months, 12 months
Blood Pressure measured after 5 minutes of rest and taken in the same position throughout the study.
Baseline, 6 months, 12 months
Change in HbA1c (fasting, CLIA-waived assay)
Tidsram: Baseline, 6 months, 12 months
Blood (~20 mL) will be collected to assess changes in glycosloated hemoglobin
Baseline, 6 months, 12 months
Change in Fasting lipid panel (total cholesterol, HDL, LDL, triglycerides)
Tidsram: Baseline, 6 months, 12 months
Fasting lipid panel will measured to assess changes in total cholesterol, HDL, LDL, and triglycerides.
Baseline, 6 months, 12 months
Change in Skin carotenoids
Tidsram: Baseline, 6 months, 12 months
Skin carotenoids will be assessed using a VeggieMeter as an indicator for fruit and vegetable intake.
Baseline, 6 months, 12 months
Change in Physical activity steps
Tidsram: Baseline, 6 months, 12 months
Steps will be measured using an activity tracker e.g., Fitbit
Baseline, 6 months, 12 months
Change in Self-Regulation of Eating Behaviors
Tidsram: Baseline, 6 months, 12 months
The Eating Behavior Inventory (20 items) measures the adoption of eating behaviors associated with weight loss (e.g., monitoring quantity eaten, frequency of weighing, shopping from a list) to measure self-regulation behaviors. Items are rated on a 5-point frequency scale from "never or hardly ever" to "always or almost always." Scores range from 26 to 130
Baseline, 6 months, 12 months
Change in Self-Efficacy of Eating Behaviors
Tidsram: Baseline, 6 months, 12 months
Measured by survey responses to the Weight Efficacy Lifestyle Questionnaire Short Form (WEL-SF).Scale goes from 0 (not at all confident) to 10 (very confident). Higher scores mean better self efficacy.
Baseline, 6 months, 12 months
Change in Self-Efficacy of Physical Activity
Tidsram: Baseline, 6 months, 12 months
The confidence subscale of the Patient-centered Assessment and Counseling for Exercise Adult Diet and Physical Activity Measure (6 items; ) measures confidence in participating in regular exercise or physical activity in different situations (e.g., "How confident are you that you would participate in regular exercise or physical activity: When I am tired?"). Items rated on a scale from 1 ("not at all confident") to 6 ("extremely confident"). Higher scores show higher self-efficacy.
Baseline, 6 months, 12 months
Change in Social Support for Eating
Tidsram: Baseline, 6 months, 12 months
The Social Support and Eating Habits Survey (10 items) measures social support specific to healthy eating. Subscales assess encouragement for eating behaviors from partners (e.g., "Encouraged me not to eat 'unhealthy food' when I am tempted") and discouragement for eating behaviors from partners (e.g., "Brought home foods I am trying not to eat"). The items are rated on a scale of "none" to "very often." Total scores range from 5 to 50, with higher scores indicating more social support for eating behaviors.
Baseline, 6 months, 12 months
Change in Social Support for Exercise
Tidsram: Baseline, 6 months, 12 months
The exercise participation subscale of the Social Support and Exercise Survey (10 items) measures social support specific to exercise behaviors. The subscale assesses the level of support for exercise from partners. Subscale example items include "Exercised with me" and "Criticized or made fun of me for exercising." Total scores range from 5 to 50, with higher scores indicating more social support for exercise participation behaviors.
Baseline, 6 months, 12 months
Change in Family Communication
Tidsram: Baseline, 6 months, 12 months
Family communication is assessed with the communication subscale of the McMaster Family Assessment Device (6 items). Communication is defined as the exchange of information among family members. Items focused on whether verbal messages were clear and direct for the intended recipient. Responses ranged from "strongly agree" to "strongly disagree." Higher scores represent unhealthy communication.
Baseline, 6 months, 12 months
Change in Family Cohesion
Tidsram: Baseline, 6 months, 12 months
The cohesion subscale (10 items) of the Family Adaptability and Cohesion Evaluation Scale III measures the emotional bonding family members have with one another. Items like "Family members ask each other for help" rated on a 5-point Likert scale from "almost never" to "almost always."
Baseline, 6 months, 12 months
Change in Family Emotional Involvement
Tidsram: Baseline, 6 months, 12 months
The family emotional involvement (7 items) of the Family Emotional Involvement and Criticism Scale rate items on a 5-point Likert scale, as above.
Baseline, 6 months, 12 months
Change in Family Perceived Criticism
Tidsram: Baseline, 6 months, 12 months
The perceived criticism (7 items) subscales of the Family Emotional Involvement and Criticism Scale rate items like on a 5-point Likert scale, as above.
Baseline, 6 months, 12 months
Change in Family Collaborative problem solving
Tidsram: Baseline, 6 months, 12 months
The Family Problem-Solving Communication Index (10 items) was used to measure the specific communication style that families use to manage and solve problems and conflicts in various types of stressful situations. Consisting of 2 subscales, affirmatory communication and incendiary communication, the response options were "false," "mostly false," "mostly true," and "true."
Baseline, 6 months, 12 months

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Candice L Alick, PhD, Morehouse School of Medicine
  • Huvudutredare: Tennille Leak-Johnson, PhD, Morehouse School of Medicine

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Beräknad)

1 november 2026

Primärt slutförande (Beräknad)

31 januari 2031

Avslutad studie (Beräknad)

31 januari 2031

Studieregistreringsdatum

Först inskickad

6 september 2026

Först inskickad som uppfyllde QC-kriterierna

6 september 2026

Första postat (Faktisk)

11 september 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

11 september 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

6 september 2026

Senast verifierad

1 september 2026

Mer information

Termer relaterade till denna studie

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera